共被期刊论文引用了2次
您的检索式：您选中1篇文献正在查看引证文献汇总
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers- Review显示文摘Venous thromboembolism event(VTE) is a common and morbid complication in cancer patients. Patients with gastrointestinal cancers often suffer from symptomatic or incidental splanchnic vein thrombosis, impaired liver function and/or thrombocytopenia. These characteristics require a thorough risk/benefit evaluation for individual patients. Considering the risk factors for the development of VTE and bleeding events in addition to recent study results may be helpful for correct initiation of primary pharmacological prevention and treatment of cancer-associated thrombosis(CAT), preferably with low molecular weight heparins(LMWH). Whereas thromboprophylaxis is most often recommended in hospitalized surgical and non-surgical patients with malignancy, there is less agreement as to its duration. With regard to ambulatory cancer patients, the lack of robust data results in low grade recommendations against routine use of anticoagulant drugs. Anticoagulation with LMWH for the first months is the evidence-based treatment for acute CAT, but duration of secondary prevention and the drug of choice are unclear. Based on published guidelines and literature, this review will focus on prevention and treatment strategies of VTE in patients with gastrointestinal cancers. | Hanno Riess Piet Habbel Anja Jühling Marianne Sinn Uwe Pelzer | 2016 | World Journal of Gastrointestinal Oncology2016，8，3： | 9 |
| 2 | 阿哌沙班防治静脉血栓栓塞概述显示文摘肝素与维生素K拮抗剂一直是防治静脉血栓栓塞症(VTE)的中流砥柱。近年来,全新的口服抗凝制剂,如达比加群、利伐沙班等逐渐开始用于VTE的防治,而口服抗凝制剂也表现出与维生素K拮抗剂、肝素等抗凝药相似的VTE治疗效果。基于现有文献资料,探讨了阿哌沙班预防和治疗VTE的效果。 | 刘羽 戴德银 陈路佳 卢海波 | 2015 | 中国药业2015，24，24： | 5 |
您所在的机构暂未开通此部分的功能，请联系管理员